CurrentRheuma
Get Weekly

Topic · page 25 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 961–1,000 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

  1. J Rheumatol

    Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

    Secondary analysis

  2. Semin Arthritis Rheum

    Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies

    Meta-analysis

  3. Clin Exp Rheumatol

    Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study

    Cross-sectional study

  4. J Rheumatol

    Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Meta-analysis

  5. J Rheumatol

    Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors

    Cohort study

  6. J Rheumatol

    Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Meta-analysis

  7. J Rheumatol

    Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Meta-analysis

  8. J Rheumatol

    Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Research article

  9. J Rheumatol

    Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Research article

  10. J Rheumatol

    Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Research article

  11. Arthritis Care Res (Hoboken)

    Incidence of Ankylosing Spondylitis Among Male and Female United States Army Personnel

    Cohort study

  12. Joint Bone Spine

    The impact of diet on disease activity in spondyloarthritis: A systematic literature review

    Cohort study

  13. Rheumatology (Oxford)

    External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab

    Diagnostic or prognostic study

  14. Rheumatology (Oxford)

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study

    Randomized controlled trial

  15. Rheumatology (Oxford)

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study

    Randomized controlled trial

  16. Ann Rheum Dis

    Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

    Cohort study

  17. Ann Rheum Dis

    ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

    Guideline or statement

  18. Ann Rheum Dis

    Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

    Research article

  19. J Rheumatol

    Sex-Based Differences in Sonographic and Clinical Findings Among Patients With Psoriatic Arthritis

    Cross-sectional study

  20. J Rheumatol

    Identifying Axial Spondyloarthritis in Patients With Inflammatory Bowel Disease Using Computed Tomography

    Cross-sectional study

  21. J Rheumatol

    Sex-Specific Differences in Patients With Psoriatic Arthritis: A Systematic Review

    Meta-analysis

  22. J Rheumatol

    Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

    Guideline or statement

  23. Clin Exp Rheumatol

    Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations

    Cross-sectional study

  24. Rheumatology (Oxford)

    The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?

    Cohort study

  25. Rheumatology (Oxford)

    Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial

    Secondary analysis

  26. J Rheumatol

    Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study

    Case-control study

  27. Rheumatology (Oxford)

    Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study

    Randomized controlled trial

  28. Joint Bone Spine

    Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis

    Cohort study

  29. Rheumatology (Oxford)

    An ankylosing spondylitis risk variant alters osteoclast differentiation

    Case-control study

  30. Rheumatology (Oxford)

    Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis

    Meta-analysis

  31. Ann Rheum Dis

    Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study

    Randomized controlled trial

  32. Rheumatology (Oxford)

    Treating spondyloarthritis early: does it matter? Results from a systematic literature review

    Research article

  33. Rheumatology (Oxford)

    Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT

    Cross-sectional study

  34. Rheumatology (Oxford)

    The influence of age on the prevalence of inflammatory and structural MRI lesions in the sacroiliac joints of patients with and without axial spondyloarthritis

    Cohort study

  35. J Rheumatol

    Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis

    Cross-sectional study

  36. Clin Exp Rheumatol

    Risk of cancer, tuberculosis and serious infections in patients with ankylosing spondylitis, psoriatic arthritis and psoriasis treated with IL-17 and TNF-α inhibitors: a nationwide nested case-control analysis

    Case-control study

  37. Rheumatology (Oxford)

    Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study

    Cross-sectional study

  38. J Rheumatol

    Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe

    Cross-sectional study

  39. J Rheumatol

    Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis

    Cross-sectional study

  40. Clin Exp Rheumatol

    HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients

    Cohort study

All 1,039 Briefs in ExploreShowing Briefs 961–1,000 of 1,039, newest first